Subscribe

PetMed Express, Inc. (PETS)

USD1.91 -0.01 (-0.26%)
US NASDAQ Healthcare Medical - Pharmaceuticals
Address 420 South Congress Avenue 33445
Delray Beach, FL, US
CEO Leslie C. G. Campbell
IPO 1999-04-26
CIK 1040130 ISIN US7163821066

Explore sections of this company profile

Description

PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD1.91 -0.01 (-0.26%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
561.5K
Beta
0.77
Float Shares
13.89M
Free Float %
64.9%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.84% -2.29% -7.39% -21.98% +23.12% -33.44% -44.24% -86.65% -95.38% -88.71% -74.57%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (10 ratings, all time) Hold
Price Targets & DCF
Current price
1.91
Low 7.00 +266.5%
Consensus 11.00 +475.9%
Median 7.00 +266.5%
High 19.00 +894.8%
DCF (Unlevered) 8.59 +349.7%
DCF (Levered) 11.56 +505.5%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 0% Bullish
Rating 2026-06 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 1 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year
All Time 4
13.25
+593.7%
Quality scores
Altman Z-Score
0.51
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Pharmaceuticals: +7.8%
    -21.1% Q1'26: -7.9% (vs Q1'25)
  • EPS growth Medical - Pharmaceuticals: +20.2%
    -813.3% Q1'26: +66.1% (vs Q1'25)
  • FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%
    -29.3% Q1'26: -12.8% (vs Q1'25)
  • EBIT margin Medical - Pharmaceuticals: +6.8%
    +0.0% Q1'26: +0.0% (vs Q1'25)
  • ROIC Medical - Pharmaceuticals: +6.1%
    +0.0% Q1'26: +0.0% (vs Q1'25)
  • Share dilution Medical - Pharmaceuticals: +0.0%
    +1.6% Q1'26: +1.9% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×
    -0.01× Q1'26: -0.28× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.79) × ERP
WACC = 99% × Ke + 1% × Kd (95.5%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 1.91
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2005
actual
Mar 2006
actual
Mar 2007
actual
Mar 2008
actual
Mar 2009
actual
Mar 2010
actual
Mar 2011
actual
Mar 2012
actual
Mar 2013
actual
Mar 2014
actual
Mar 2015
actual
Mar 2016
actual
Mar 2017
actual
Mar 2018
actual
Mar 2019
actual
Mar 2020
actual
Mar 2021
actual
Mar 2022
actual
Mar 2023
actual
Mar 2024
actual
Mar 2025
actual
Mar 2026
1 Rev. Ana.
1 EPS Ana.
Mar 2027
1 Rev. Ana.
1 EPS Ana.
Mar 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
108.36M
est: 111.72M (-3.0%)
137.58M
est: 117.63M (+17.0%)
162.25M
est: 151.07M (+7.4%)
188.34M
est: 161.28M (+16.8%)
219.41M
est: 191.31M (+14.7%)
238.27M
est: 217.61M (+9.5%)
231.64M
est: 256.12M (-9.6%)
238.25M
est: 227.35M (+4.8%)
227.83M
est: 217.88M (+4.6%)
233.39M
est: 228.13M (+2.3%)
229.40M
est: 228.51M (+0.4%)
234.68M
est: 229.52M (+2.2%)
249.18M
est: 242.67M (+2.7%)
273.80M
est: 274.89M (-0.4%)
283.42M
est: 287.91M (-1.6%)
284.13M
est: 276.10M (+2.9%)
303.58M
est: 313.90M (-3.3%)
273.42M
est: 276.80M (-1.2%)
256.58M
est: 262.73M (-2.3%)
274.10M
est: 270.77M (+1.2%)
226.97M
est: 230.15M (-1.4%)
178.48M
178.48M – 178.48M
-22.4% YoY
180.32M
180.32M – 180.32M
+1.0% YoY
184.40M
184.40M – 184.40M
+2.3% YoY
EBITDA
13.08M
est: 10.37M (+26.0%)
18.69M
est: 14.88M (+25.6%)
22.03M
est: 22.32M (-1.3%)
28.59M
est: 25.25M (+13.2%)
35.02M
est: 31.09M (+12.6%)
41.86M
est: 37.61M (+11.3%)
34.40M
est: 41.05M (-16.2%)
27.43M
est: 26.27M (+4.4%)
28.10M
est: 24.36M (+15.3%)
29.09M
est: 28.36M (+2.6%)
30.04M
est: 27.16M (+10.6%)
33.16M
est: 31.78M (+4.3%)
38.85M
est: 35.68M (+8.9%)
54.26M
est: 36.29M (+49.5%)
51.35M
est: 58.17M (-11.7%)
36.15M
est: 36.79M (-1.7%)
32.96M
est: 39.52M (-16.6%)
29.81M
est: 15.27M (+95.2%)
10.99M
est: 32.72M (-66.4%)
783.0K
est: 15.86M (-95.1%)
6.71M
est: 13.48M (-50.2%)
10.45M
10.45M – 10.45M
-22.4% YoY
10.56M
10.56M – 10.56M
+1.0% YoY
10.80M
10.80M – 10.80M
+2.3% YoY
EBIT
12.50M
est: 9.76M (+28.1%)
18.15M
est: 13.89M (+30.6%)
21.50M
est: 20.29M (+5.9%)
28.00M
est: 22.77M (+23.0%)
34.20M
est: 28.91M (+18.3%)
40.54M
est: 36.09M (+12.3%)
33.02M
est: 39.37M (-16.1%)
26.02M
est: 24.62M (+5.7%)
27.31M
est: 23.01M (+18.7%)
28.40M
est: 27.27M (+4.2%)
29.33M
est: 26.32M (+11.4%)
32.39M
est: 30.89M (+4.8%)
37.92M
est: 34.25M (+10.7%)
53.79M
est: 33.99M (+58.3%)
49.12M
est: 53.17M (-7.6%)
33.89M
est: 31.12M (+8.9%)
30.53M
est: 35.66M (-14.4%)
27.07M
est: 10.40M (+160.2%)
7.45M
est: 27.54M (-73.0%)
-6.27M
est: 11.06M (-156.7%)
-330.0K
est: 9.40M (-103.5%)
7.29M
7.29M – 7.29M
-22.4% YoY
7.37M
7.37M – 7.37M
+1.0% YoY
7.53M
7.53M – 7.53M
+2.3% YoY
Net Income
8.01M
est: 6.26M (+28.0%)
12.06M
est: 9.33M (+29.3%)
14.44M
est: 13.60M (+6.2%)
20.02M
est: 16.11M (+24.2%)
22.98M
est: 19.74M (+16.4%)
26.00M
est: 23.30M (+11.6%)
20.87M
est: 24.70M (-15.5%)
16.66M
est: 15.80M (+5.4%)
17.17M
est: 14.65M (+17.2%)
17.97M
est: 17.37M (+3.5%)
17.45M
est: 16.65M (+4.8%)
20.57M
est: 19.64M (+4.7%)
23.82M
est: 21.66M (+10.0%)
37.28M
est: 23.45M (+59.0%)
37.74M
est: 42.05M (-10.2%)
25.85M
est: 26.33M (-1.8%)
23.92M
est: 29.12M (-17.9%)
21.10M
est: 21.16M (-0.3%)
5.14M
est: 22.42M (-77.1%)
-7.46M
est: -2.59M (-187.8%)
-6.27M
est: -1.65M (-280.6%)
-56.02M
-56.02M – -56.02M
-3,300.0% YoY
1.44M
1.44M – 1.44M
+102.6% YoY
1.85M
1.85M – 1.85M
+28.6% YoY
SGA
30.58M
est: 31.37M (-2.5%)
35.65M
est: 28.83M (+23.7%)
42.54M
est: 39.78M (+6.9%)
45.63M
est: 39.36M (+15.9%)
50.31M
est: 43.77M (+14.9%)
50.00M
est: 45.83M (+9.1%)
49.56M
est: 53.45M (-7.3%)
52.73M
est: 47.46M (+11.1%)
49.03M
est: 46.36M (+5.7%)
48.53M
est: 47.16M (+2.9%)
46.28M
est: 47.35M (-2.3%)
43.14M
est: 41.94M (+2.9%)
40.46M
est: 39.40M (+2.7%)
43.55M
est: 29.41M (+48.1%)
46.92M
est: 45.99M (+2.0%)
48.01M
est: 51.72M (-7.2%)
49.93M
est: 48.27M (+3.5%)
49.63M
est: 64.94M (-23.6%)
68.90M
est: 59.62M (+15.6%)
79.75M
est: 63.93M (+24.7%)
62.43M
est: 54.34M (+14.9%)
42.14M
42.14M – 42.14M
-22.4% YoY
42.58M
42.58M – 42.58M
+1.0% YoY
43.54M
43.54M – 43.54M
+2.3% YoY
EPS
0.35
est: 0.31 (+14.8%)
0.51
est: 0.34 (+52.2%)
0.60
est: 0.56 (+7.1%)
0.83
est: 0.58 (+43.1%)
0.99
est: 0.76 (+30.3%)
1.15
est: 0.96 (+19.8%)
0.93
est: 1.21 (-23.1%)
0.81
est: 0.75 (+8.0%)
0.86
est: 0.69 (+24.6%)
0.90
est: 0.85 (+5.9%)
0.87
est: 0.91 (-3.9%)
1.02
est: 0.99 (+2.5%)
1.18
est: 1.06 (+10.8%)
1.83
est: 1.80 (+1.9%)
1.84
est: 1.98 (-7.2%)
1.29
est: 1.23 (+5.1%)
1.53
est: 1.61 (-4.7%)
1.05
est: 1.03 (+2.2%)
0.25
est: 0.42 (-40.5%)
-0.37
est: -0.13 (-193.8%)
-0.30
est: -0.08 (-275.0%)
-2.72
-2.72 – -2.72
-3,300.0% YoY
0.07
0.07 – 0.07
+102.6% YoY
0.09
0.09 – 0.09
+28.6% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-06-02 B- 3/5 5/5 1/5 1/5 4/5 1/5 3/5
2026-06-01 B- 3/5 5/5 1/5 1/5 4/5 1/5 3/5
2026-05-28 B- 3/5 5/5 1/5 1/5 4/5 1/5 3/5
2026-05-27 B- 3/5 5/5 1/5 1/5 4/5 1/5 3/5
2026-05-26 B- 3/5 5/5 1/5 1/5 4/5 1/5 3/5
2026-05-22 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-21 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-20 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-19 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-18 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-15 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-14 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-13 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-12 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-11 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-08 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-07 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-06 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-05 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-04 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-05-01 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-04-30 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-04-29 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-04-28 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-04-27 B- 2/5 5/5 1/5 1/5 3/5 1/5 3/5
2026-04-24 C+ 2/5 5/5 1/5 1/5 2/5 1/5 3/5
2026-04-23 C+ 2/5 5/5 1/5 1/5 2/5 1/5 3/5
2026-04-22 C+ 2/5 5/5 1/5 1/5 2/5 1/5 3/5
2026-04-21 C+ 2/5 5/5 1/5 1/5 2/5 1/5 3/5
2026-04-20 C+ 2/5 5/5 1/5 1/5 2/5 1/5 3/5
2026-04-17 C+ 2/5 5/5 1/5 1/5 2/5 1/5 3/5
2026-04-16 C+ 2/5 5/5 1/5 1/5 2/5 1/5 3/5
2026-04-15 C+ 2/5 5/5 1/5 1/5 2/5 1/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
-29.23M
OE per share TTM
-1.40
Owner's Yield
-65.25%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
9.8%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
10
Total invested
1.35M
Insider transactions (90d)
0
Beneficial owners (>5%)
29
Beneficial owners (>5%)
# Reporting person Amount owned % of class Sole voting Shared voting Sole dispositive Shared dispositive Type Citizenship Filing date SEC filing
1 (1) BlackRock, Inc. 3.29M 15.70% 3.25M 3.29M HC Delaware 2022-01-27
2 Moises Tache Galante 2.08M 10.08% 2.08M 2.08M IN Spain 2024-10-10
3 04-2683227 1.70M 7.47% 1.23M IA Massachusetts 2011-02-14
4 Nina Capital Holdings Inc. 1.55M 7.52% 1.55M 1.55M CO British Virgin Islands 2024-10-10
5 Neuberger Berman Group LLC 1.53M 6.71% 1.29M 1.53M HC Delaware 2010-02-17
6 Neuberger Berman LLC 1.53M 6.71% 1.29M 1.53M IA Delaware 2010-02-17
7 Neuberger Berman Equity Funds 1.53M 5.63% 1.53M 1.53M IV Delaware 2010-02-17
8 The Vanguard Group - 23-1945930 1.41M 6.71% 36.2K 1.35M 51.4K IA Pennsylvania For 2022-02-10
9 ALLIANZ GLOBAL INVESTORS CAPITAL LLC 1.37M 6.00% IA, HC, OO Delaware 2011-02-14
10 13-3127734 1.34M 6.36% 1.34M 1.34M HC Delaware 2024-02-13
11 26-0385758 1.34M 6.36% 1.34M 1.34M IA Delaware 2024-02-13
12 ALLIANZ GLOBAL INVESTORS U.S. HOLDINGS LLC 1.32M 6.50% HC, OO Delaware 2015-02-13
13 1,306,413 1.31M 6.32% 1.31M 1.31M CO USA 2019-02-08
14 Neuberger Berman Management LLC 1.29M 5.66% 1.29M 1.29M BD Delaware 2010-02-17
15 NFJ Investment Group LLC 1.28M 6.30% 1.28M 1.28M IA, OO Delaware 2015-02-13
16 Brown Capital Management, Inc. 1.25M 5.47% 612.6K 612.6K 612.6K 612.6K IA, CO Maryland 2010-04-26
17 Andrew A. Ziegler 1.23M 5.40% 1.18M 1.23M IN Wisconsin 2011-02-10
18 Artisan Investment Corporation 1.23M 5.40% 1.18M 1.23M HC Wisconsin 2011-02-10
19 Artisan Investments GP LLC 1.23M 5.40% 1.18M 1.23M HC Wisconsin 2011-02-10
20 Artisan Partners Holdings LP 1.23M 5.40% 1.18M 1.23M HC Wisconsin 2011-02-10
21 Artisan Partners Limited Partnership 1.23M 5.40% 1.18M 1.23M IA Wisconsin 2011-02-10
22 Carlene M. Ziegler 1.23M 5.40% 1.18M 1.23M IN Wisconsin 2011-02-10
23 ZFIC, Inc. 1.23M 5.40% 1.18M 1.23M HC Wisconsin 2011-02-10
24 Hotchkis and Wiley Capital Management, LLC 1.09M 5.29% 944.5K 1.09M IA Delaware 2024-11-14
25 ProShare Advisors LLC, ProFund Advisors LLC 1.06M 5.05% IA Maryland 2022-02-10
26 Stephannie Matz Zyman 528.0K 2.56% 528.0K 528.0K IN Mexico 2024-10-10
27 Morgan Stanley 348.5K 1.70% 241.2K 348.5K HC, CO Delaware. 2019-08-08
28 Lord, Abbett & Co. LLC 199.0K 0.87% 173.1K 199.0K IA Delaware 2010-03-10
29 10. 0.00% CO USA 2019-02-08

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2026 Q1
Investors holding
10
-46 vs prev Q
New positions
2
Closed positions
44
Increased
3
Reduced
2
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 STEEL PARTNERS HOLDINGS L.P. 193.7K +193.7K (+100.0%) 619.73M +619.7M (+100.0%) 0.92% +0.922 pp 0.50% +0.496 pp USD3.20 +0.0% 1 qtrs NEW
2 RENAISSANCE TECHNOLOGIES LLC 1.23M -42.4K (-3.3%) 3.93M +739.9K (+23.2%) 5.84% -0.310 pp 0.01% +0.002 pp USD14.02 -77.2% 73 qtrs
3 VANGUARD GROUP INC 963.8K -293.0 (0.0%) 3.08M +664.3K (+27.5%) 4.59% -0.084 pp 0.00% +0.000 pp USD28.19 -88.6% 83 qtrs
4 HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 788.1K +— (+0.0%) 2.52M +543.8K (+27.5%) 3.75% -0.067 pp 0.01% +0.001 pp USD7.20 -55.6% 10 qtrs
5 FEDERATED HERMES, INC. 627.7K +145.4K (+30.1%) 2.01M +798.0K (+65.9%) 2.99% +0.651 pp 0.00% +0.001 pp USD4.29 -25.4% 9 qtrs
6 BLACKROCK, INC. 548.0K +5.3K (+1.0%) 1.75M +391.3K (+28.7%) 2.61% -0.021 pp 0.00% +0.000 pp USD3.70 -13.5% 6 qtrs
7 DIMENSIONAL FUND ADVISORS LP 405.9K -75.6K (-15.7%) 1.30M +90.3K (+7.5%) 1.93% -0.401 pp 0.00% +0.000 pp USD10.15 -68.5% 51 qtrs
8 376.00 +376.0 (+100.0%) 1.20M +1.2M (+100.0%) 0.00% +0.002 pp 0.00% +0.001 pp USD3.20 +0.0% 1 qtrs NEW
9 UBS GROUP AG 329.6K +243.6K (+282.9%) 1.05M +838.8K (+388.2%) 1.57% +1.152 pp 0.00% +0.000 pp USD3.79 -15.6% 45 qtrs
10 GEODE CAPITAL MANAGEMENT, LLC 205.5K +2.0K (+1.0%) 657.8K +146.9K (+28.8%) 0.98% -0.008 pp 0.00% +0.000 pp USD23.03 -86.1% 78 qtrs
11 ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 175.2K +— (+0.0%) 560.7K +120.9K (+27.5%) 0.83% -0.015 pp 0.00% +0.000 pp USD6.91 -53.7% 11 qtrs
12 MAN GROUP PLC 167.2K +16.1K (+10.7%) 534.9K +155.8K (+41.1%) 0.80% +0.064 pp 0.00% +0.000 pp USD12.78 -75.0% 32 qtrs
13 BRIDGEWAY CAPITAL MANAGEMENT, LLC 126.4K +18.5K (+17.2%) 404.3K +133.7K (+49.4%) 0.60% +0.079 pp 0.01% +0.003 pp USD3.02 +6.0% 8 qtrs
14 PRICE T ROWE ASSOCIATES INC /MD/ 120.1K +— (+0.0%) 385.0K +83.0K (+27.5%) 0.57% -0.010 pp 0.00% +0.000 pp USD11.61 -72.4% 52 qtrs
15 STATE STREET CORP 105.2K +7.6K (+7.8%) 336.6K +91.6K (+37.4%) 0.50% +0.028 pp 0.00% +0.000 pp USD20.00 -84.0% 51 qtrs
16 AMERIPRISE FINANCIAL INC 104.0K -173.0 (-0.2%) 332.8K +71.3K (+27.3%) 0.50% -0.010 pp 0.00% +0.000 pp USD6.54 -51.1% 56 qtrs
17 RANGELEY CAPITAL, LLC 75.0K +75.0K (+100.0%) 240.0K +240.0K (+100.0%) 0.36% +0.357 pp 0.20% +0.199 pp USD3.20 +0.0% 1 qtrs NEW
18 FORMIDABLE ASSET MANAGEMENT, LLC 93.1K -5.9K (-6.0%) 233.6K -95.1K (-28.9%) 0.45% -0.034 pp 0.03% -0.018 pp USD7.90 -59.5% 20 qtrs
19 EMPOWERED FUNDS, LLC 68.7K +8.5K (+14.2%) 219.7K +68.8K (+45.6%) 0.33% +0.036 pp 0.00% +0.000 pp USD2.83 +13.1% 3 qtrs
20 UMB BANK, N.A. 60.0K +60.0K (+100.0%) 192.0K +192.0K (+100.0%) 0.29% +0.286 pp 0.00% +0.003 pp USD3.20 +0.0% 1 qtrs NEW
21 AMERICAN CENTURY COMPANIES INC 59.9K +— (+0.0%) 191.7K +41.3K (+27.5%) 0.29% -0.005 pp 0.00% +0.000 pp USD6.46 -50.5% 11 qtrs
22 NORTHERN TRUST CORP 58.8K -2.4K (-4.0%) 188.3K +34.5K (+22.4%) 0.28% -0.017 pp 0.00% +0.000 pp USD12.40 -74.2% 51 qtrs
23 SUSQUEHANNA INTERNATIONAL GROUP, LLP 46.9K +12.2K (+35.2%) 150.2K +63.1K (+72.4%) 0.22% +0.055 pp 0.00% +0.000 pp USD3.35 -4.5% 15 qtrs
24 GAGNON SECURITIES LLC 42.3K +18.5K (+77.5%) 135.5K +75.6K (+126.3%) 0.20% +0.086 pp 0.03% +0.016 pp USD13.82 -76.8% 20 qtrs
25 JANE STREET GROUP, LLC 33.0K +33.0K (+100.0%) 105.6K +105.6K (+100.0%) 0.16% +0.157 pp 0.00% +0.000 pp USD3.20 +0.0% 1 qtrs NEW
26 CIBC PRIVATE WEALTH GROUP, LLC 30.0K +— (+0.0%) 96.0K +20.7K (+27.5%) 0.14% -0.003 pp 0.00% +0.000 pp USD2.51 +27.5% 2 qtrs
27 LEVIN CAPITAL STRATEGIES, L.P. 25.0K +25.0K (+100.0%) 80.0K +80.0K (+100.0%) 0.12% +0.120 pp 0.01% +0.007 pp USD3.20 +0.0% 1 qtrs NEW
28 GOLDMAN SACHS GROUP INC 24.7K -4.0K (-14.0%) 79.1K +7.0K (+9.7%) 0.12% -0.022 pp 0.00% +0.000 pp USD4.98 -35.7% 73 qtrs
29 JAIN GLOBAL LLC 24.3K +24.3K (+100.0%) 77.7K +77.7K (+100.0%) 0.12% +0.116 pp 0.00% +0.000 pp USD3.20 +0.0% 1 qtrs NEW
30 CITADEL ADVISORS LLC 21.2K -2.6K (-10.9%) 67.8K +8.1K (+13.6%) 0.10% -0.014 pp 0.00% +0.000 pp USD5.59 -42.8% 35 qtrs
31 SEI INVESTMENTS CO 16.2K +— (+0.0%) 51.8K +11.2K (+27.5%) 0.08% -0.001 pp 0.00% +0.000 pp USD7.54 -57.6% 10 qtrs
32 MORGAN STANLEY 13.3K +9.1K (+214.6%) 42.5K +31.9K (+301.1%) 0.06% +0.043 pp 0.00% +0.000 pp USD5.40 -40.7% 51 qtrs
33 XTX TOPCO LTD 10.3K -15.4K (-60.0%) 32.9K -31.6K (-49.0%) 0.05% -0.076 pp 0.00% -0.003 pp USD2.51 +27.5% 2 qtrs
34 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 10.1K +67.0 (+0.7%) 32.2K +7.1K (+28.3%) 0.05% -0.001 pp 0.00% +0.000 pp USD19.03 -83.2% 68 qtrs
35 BNP PARIBAS ARBITRAGE, SNC 8.8K -287.0 (-3.2%) 28.1K +5.3K (+23.5%) 0.04% -0.002 pp 0.00% +0.000 pp USD5.57 -42.5% 49 qtrs
36 ADVISOR GROUP HOLDINGS, INC. 3.5K -179.0 (-4.8%) 11.3K +1.7K (+17.4%) 0.02% -0.001 pp 0.00% +0.000 pp USD25.18 -87.3% 24 qtrs
37 GROUP ONE TRADING, L.P. 3.1K -10.8K (-77.6%) 9.9K -24.8K (-71.5%) 0.01% -0.052 pp 0.00% +0.000 pp USD2.51 +27.5% 2 qtrs
38 SBI SECURITIES CO., LTD. 1.2K -4.0 (-0.3%) 3.9K +824.0 (+27.1%) 0.01% 0.000 pp 0.00% +0.000 pp USD4.82 -33.6% 5 qtrs
39 BANK & TRUST CO 901.00 -1.8K (-66.1%) 2.9K -3.8K (-56.8%) 0.00% -0.009 pp 0.00% -0.003 pp USD4.04 -20.8% 7 qtrs
40 BANK OF AMERICA CORP /DE/ 746.00 +1.0 (+0.1%) 2.4K +518.0 (+27.7%) 0.00% 0.000 pp 0.00% +0.000 pp USD8.17 -60.8% 52 qtrs
41 HARBOUR INVESTMENTS, INC. 554.00 +14.0 (+2.6%) 1.8K +418.0 (+30.8%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.02 -20.4% 7 qtrs
42 ALLWORTH FINANCIAL LP 494.00 +— (+0.0%) 1.6K +341.0 (+27.5%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.38 -26.9% 5 qtrs
43 WELLS FARGO & COMPANY/MN 476.00 +121.0 (+34.1%) 1.5K +632.0 (+71.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD4.42 -27.6% 57 qtrs
44 FMR LLC 400.00 -150.0 (-27.3%) 1.3K -101.0 (-7.3%) 0.00% -0.001 pp 0.00% +0.000 pp USD5.70 -43.9% 30 qtrs
45 MCF ADVISORS LLC 400.00 +400.0 (+100.0%) 1.3K +1.3K (+100.0%) 0.00% +0.002 pp 0.00% +0.000 pp USD3.20 +0.0% 1 qtrs NEW
46 ROTHSCHILD INVESTMENT LLC 250.00 +— (+0.0%) 800.00 +172.0 (+27.4%) 0.00% +0.000 pp 0.00% +0.000 pp USD7.56 -57.7% 9 qtrs
47 JONES FINANCIAL COMPANIES LLLP 209.00 +— (+0.0%) 668.00 +115.0 (+20.8%) 0.00% +0.000 pp 0.00% +0.000 pp USD4.82 -33.6% 7 qtrs
48 AMERIFLEX GROUP, INC. 100.00 +100.0 (+100.0%) 320.00 +320.0 (+100.0%) 0.00% +0.001 pp 0.00% +0.000 pp USD3.20 +0.0% 1 qtrs NEW
49 ELEVATED CAPITAL ADVISORS, LLC 50.00 +50.0 (+100.0%) 160.00 +160.0 (+100.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.20 +0.0% 1 qtrs NEW
50 CORECAP ADVISORS, LLC 4.00 +— (+0.0%) 13.00 +3.0 (+30.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD3.50 -8.6% 8 qtrs
51 HUNTINGTON NATIONAL BANK 1.00 +— (+0.0%) 3.00 +— (+0.0%) 0.00% +0.000 pp 0.00% +0.000 pp USD8.00 -60.0% 13 qtrs
52 FEDERATION DES CAISSES DESJARDINS DU QUEBEC -418.0 (-100.0%) -1.0K (-100.0%) 0.00% -0.002 pp 0.00% +0.000 pp USD 36 qtrs SOLD
53 SIMPLEX TRADING, LLC -17.7K (-100.0%) -44.0K (-100.0%) 0.00% -0.086 pp 0.00% +0.000 pp USD 9 qtrs SOLD
54 JPMORGAN CHASE & CO -5.9K (-100.0%) -14.7K (-100.0%) 0.00% -0.028 pp 0.00% +0.000 pp USD 41 qtrs SOLD
55 BARCLAYS PLC -57.0 (-100.0%) -143.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 2 qtrs SOLD
56 TRUFFLE HOUND CAPITAL, LLC -120.0K (-100.0%) -301.3K (-100.0%) 0.00% -0.582 pp 0.00% -0.084 pp USD 3 qtrs SOLD
57 TWO SIGMA SECURITIES, LLC -19.1K (-100.0%) -47.9K (-100.0%) 0.00% -0.092 pp 0.00% -0.007 pp USD 7 qtrs SOLD
58 INVESCO LTD. -36.1K (-100.0%) -90.6K (-100.0%) 0.00% -0.175 pp 0.00% +0.000 pp USD 57 qtrs SOLD
59 HRT FINANCIAL LP -12.8K (-100.0%) -32.0K (-100.0%) 0.00% -0.062 pp 0.00% 0.000 pp USD 2 qtrs SOLD
60 OAKTOP CAPITAL MANAGEMENT II, L.P. -435.8K (-100.0%) -1.1M (-100.0%) 0.00% -2.112 pp 0.00% -0.099 pp USD 51 qtrs SOLD
61 OCCUDO QUANTITATIVE STRATEGIES LP -12.2K (-100.0%) -30.7K (-100.0%) 0.00% -0.059 pp 0.00% -0.004 pp USD 11 qtrs SOLD
62 PRINCIPAL SECURITIES, INC. -1.4K (-100.0%) -3.6K (-100.0%) 0.00% -0.007 pp 0.00% 0.000 pp USD 9 qtrs SOLD
63 R SQUARED LTD -22.1K (-100.0%) -55.5K (-100.0%) 0.00% -0.107 pp 0.00% -0.024 pp USD 5 qtrs SOLD
64 CITIGROUP INC -32.0 (-100.0%) -80.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 54 qtrs SOLD
65 NORTH CAPITAL, INC. -25.0 (-100.0%) -63.0 (-100.0%) 0.00% 0.000 pp 0.00% +0.000 pp USD 4 qtrs SOLD
66 ROYAL BANK OF CANADA -39.4K (-100.0%) -99.0K (-100.0%) 0.00% -0.191 pp 0.00% +0.000 pp USD 51 qtrs SOLD
67 RUSSELL INVESTMENTS GROUP, LTD. -124.0 (-100.0%) -311.0 (-100.0%) 0.00% -0.001 pp 0.00% +0.000 pp USD 37 qtrs SOLD
Ownership breakdown by holder

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
1
Shares acquired
Shares disposed
26.1K
Cash buys
Cash sales
Net activity
-26,057
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-01-21 FULGONI GIAN Director D-Return D Common Stock 26,057 0.00 132,299 D
2025-10-30 Solivan Leah Director A-Award A Common Stock 33,846 0.00 42,289 D
2025-10-30 Mennen Justin L. Director A-Award A Common Stock 33,846 0.00 42,719 D
2025-10-30 LaCamp James Director A-Award A Common Stock 34,866 0.00 34,866 D
2025-10-30 KRULIK DOUGLAS Officer A-Award A Common Stock 20,000 0.00 70,000 D
2025-10-30 FULGONI GIAN Director A-Award A Common Stock 33,846 0.00 158,356 D
2025-10-30 Batushansky Peter Director A-Award A Common Stock 33,846 0.00 36,373 D
2025-10-19 LaCamp James Director 0 0.00 0
2025-09-09 KRULIK DOUGLAS Officer A-Award A Common Stock 10,000 0.00 50,000 D
2025-08-13 Silvercape Investments Ltd 10% Owner P-Purchase A Common Stock, par value $0.001 101,000 3.17 320.2K 2,579,696 D
2025-08-01 Silvercape Investments Ltd 10% Owner P-Purchase A Common Stock, par value $0.001 118,200 3.21 379.4K 2,478,696 D
2025-07-21 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 25,000 3.50 87.4K 2,575,000 D
2025-07-18 Silvercape Investments Ltd 10% Owner P-Purchase A Common Stock, par value $0.001 17,565 3.23 56.7K 2,360,496 D
2025-07-17 Silvercape Investments Ltd 10% Owner P-Purchase A Common Stock, par value $0.001 31,701 3.15 99.9K 2,342,931 D
2025-07-02 Silvercape Investments Ltd 10% Owner P-Purchase A Common Stock, par value $0.001 2,817 3.22 9.1K 2,311,230 D
2025-07-01 Silvercape Investments Ltd 10% Owner P-Purchase A Common Stock, par value $0.001 694 3.21 2.2K 2,308,413 D
2025-06-03 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 25,000 3.94 98.4K 2,550,000 D
2025-05-21 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 25,000 3.86 96.5K 2,525,000 D
2025-05-20 Silvercape Investments Ltd 10% Owner P-Purchase A Common Stock, par value $0.001 7,401 3.95 29.2K 2,307,719 D
2025-04-30 Campos Sandra Yvette Director / Officer S-Sale D Common Stock 58,898 3.31 194.9K 580,089 D
2025-04-09 Batushansky Peter Director 0 0.00 0
2025-03-27 Silvercape Investments Ltd 10% Owner Common Stock, par value $0.001 0 0.00 2,300,318 D
2025-03-18 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 100,000 4.09 408.5K 2,500,000 D
2025-03-10 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 100,000 4.11 411.0K 2,400,000 D
2025-03-03 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 50,000 4.33 216.3K 2,300,000 D
2025-02-03 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 25,000 4.82 120.5K 2,250,000 D
2025-01-27 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 25,000 4.64 115.9K 2,225,000 D
2025-01-24 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 25,000 4.95 123.7K 2,200,000 D
2025-01-15 Smith Jacqueline Paula Other A-Award A Common Stock 8,000 0.00 28,099 D
2025-01-15 Campos Sandra Yvette Director / Officer A-Award A Common Stock 146,772 0.00 638,987 D
2025-01-07 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 25,000 4.98 124.4K 2,175,000 D
2024-12-16 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 32,000 5.66 181.0K 2,150,000 D
2024-12-06 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 40,000 5.55 222.0K 2,118,000 D
2024-12-05 Campbell Leslie C.G. Director P-Purchase A Common Stock 5,000 5.42 27.1K 75,000 D
2024-12-04 Campbell Leslie C.G. Director P-Purchase A Common Stock 5,000 5.38 26.9K 70,000 D
2024-09-27 KRULIK DOUGLAS Officer A-Award A Common Stock 40,000 0.00 40,000 D
2024-09-27 D'Elia Robyn M. Officer A-Award A Common Stock 250,000 0.00 250,000 D
2024-09-26 D'Elia Robyn M. Officer 0 0.00 0
2024-09-09 NINA CAPITAL HOLDINGS INC. 10% Owner P-Purchase A Common Stock 12,500 3.34 41.8K 2,078,000 D
2024-08-19 KRULIK DOUGLAS Officer 0 0.00 0
2024-08-15 Smith Jacqueline Paula Other S-Sale D Common Stock 601 3.19 1.9K 20,099
2024-08-08 Solivan Leah Director A-Award A Common Stock 7,500 0.00 8,443
2024-08-08 PURCEL DIANA G Director A-Award A Common Stock 7,500 0.00 24,375
2024-08-08 Mennen Justin L. Director A-Award A Common Stock 7,500 0.00 8,873
2024-08-08 FULGONI GIAN Director A-Award A Common Stock 7,500 0.00 124,510
2024-08-08 Campbell Leslie C.G. Director A-Award A Common Stock 7,500 0.00 55,000
2024-07-01 Solivan Leah Director A-Award A Common Stock 943 0.00 943
2024-06-24 Solivan Leah Director 0 0.00 0
2024-06-03 Mennen Justin L. Director A-Award A Common Stock 1,373 0.00 1,373
2024-05-31 Chambers Christine Officer D-Return D Common Stock 41,342 0.00 65,146
2024-05-16 Chambers Christine Officer A-Award A Common Stock 74,850 0.00 106,488
2024-04-29 Hulett Mathew N Director / Officer D-Return D Common Stock 510,000 0.00 103,850
2024-04-29 Campos Sandra Yvette Director / Officer A-Award A Common Stock -Restricted Stock Units 483,092 0.00 490,592
2023-12-11 Moseley Mark Bradley JR A-Award A Common Stock 14,000 7.14 100.0K 42,000
2023-11-09 FULGONI GIAN Director P-Purchase A Common Stock 41,000 7.34 301.1K 109,510
2023-11-03 Hulett Mathew N Director / Officer P-Purchase A Common Stock 13,850 7.26 100.6K 613,850
2023-11-03 Chambers Christine Officer P-Purchase A Common Stock 6,888 7.26 50.0K 19,888
2023-08-14 Smith Jacqueline Paula A-Award A Common Stock -Restricted Stock Units 6,000 0.00 6,000
2023-08-03 PURCEL DIANA G Director A-Award A Common Stock -Restricted Stock Units 7,500 0.00 7,500
2023-08-03 FULGONI GIAN Director A-Award A Common Stock -Restricted Stock Units 7,500 0.00 7,500
2023-08-03 Campos Sandra Yvette Director A-Award A Common Stock -Restricted Stock Units 7,500 0.00 7,500
2023-08-03 Campbell Leslie C.G. Director A-Award A Common Stock -Restricted Stock Units 7,500 0.00 7,500
2023-06-15 Chambers Christine Officer A-Award A Performance Share Units 8,000 0.00 8,000
2023-06-08 Chambers Christine Officer D-Return D Common Stock 3,000 0.00 13,000
2023-05-17 Pingree Daniel Job A-Award A Common Stock 11,000 15.48 170.3K 22,000
2023-05-17 Moseley Mark Bradley JR A-Award A Common Stock 14,000 15.48 216.7K 28,000
2023-05-17 Campos Sandra Yvette Director D Common Stock 0 0.00 1,623
2022-08-03 Chambers Christine Officer D Common Stock 0 0.00 16,000
2022-07-28 Watson Jodi Director A-Award A Common Stock 7,500 21.76 163.2K 18,880
2022-07-28 Smith Jacqueline Paula A-Award A Common Stock 7,350 21.76 159.9K 14,700
2022-07-28 PURCEL DIANA G Director A-Award A Common Stock 7,500 21.76 163.2K 9,375
2022-07-28 FULGONI GIAN Director A-Award A Common Stock 7,500 21.76 163.2K 68,510
2022-07-28 Cobb Peter Director A-Award A Common Stock 7,500 21.76 163.2K 15,000
2022-07-28 Campbell Leslie C.G. Director A-Award A Common Stock 7,500 21.76 163.2K 40,000
2022-04-25 Carden Carolyn D COMMON STOCK 0 0.00 6,000
2022-04-04 PURCEL DIANA G Director D Common Stock 0 0.00 1,875
2022-01-11 Watson Jodi Director A-Award A Common Stock 2,500 25.20 63.0K 11,380
2022-01-11 Campbell Leslie C.G. Director A-Award A Common Stock 2,500 25.20 63.0K 32,500
2022-01-04 Smith Jacqueline Paula D COMMON STOCK 0 0.00 7,350
2022-01-04 Pingree Daniel Job D COMMON STOCK 0 0.00 11,000
2021-12-01 Moseley Mark Bradley JR D COMMON STOCK 0 0.00 14,000
2021-08-30 Hulett Mathew N Director / Officer D Common Stock 0 0.00 600,000
2021-07-30 Watson Jodi Director A-Award A Common Stock 7,500 31.39 235.4K 8,880
2021-07-30 ROSENBLOOM BRUCE S Officer A-Award A Common Stock 14,925 31.39 468.5K 45,450
2021-07-30 KORN RONALD J Director A-Award A Common Stock 7,500 31.39 235.4K 90,833
2021-07-30 FULGONI GIAN Director A-Award A Common Stock 7,500 31.39 235.4K 61,010
2021-07-30 Cobb Peter Director D COMMON STOCK 0 0.00 7,500
2021-07-30 Campbell Leslie C.G. Director A-Award A Common Stock 7,500 31.39 235.4K 30,000
2021-06-02 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 6,000 42.50 255.0K 30,525
2021-05-25 Watson Jodi Director D Common Stock 0 0.00 1,380
2021-01-29 FORMICA FRANK J Director S-Sale D Common Stock 5,000 38.59 193.0K 55,000
2021-01-28 ROSENBLOOM BRUCE S Officer S-Sale D COMMON STOCK 5,000 50.00 250.0K 36,525
2021-01-28 FULGONI GIAN Director S-Sale D COMMON STOCK 2,890 50.93 147.2K 53,510
2021-01-27 FULGONI GIAN Director S-Sale D COMMON STOCK 10,000 46.03 460.3K 56,400
2021-01-27 AKDAG MENDERES Director / Officer S-Sale D COMMON STOCK 60,000 45.50 2.73M 337,800
2021-01-13 KORN RONALD J Director S-Sale D Common Stock 2,000 35.00 70.0K 83,333
2020-12-24 KORN RONALD J Director S-Sale D Common Stock 2,000 34.00 68.0K 85,333
2020-12-18 KORN RONALD J Director S-Sale D Common Stock 2,000 33.00 66.0K 87,333
2020-11-12 KORN RONALD J Director S-Sale D Common Stock 2,000 32.00 64.0K 89,333
2020-08-28 SCHWEITZER ROBERT C Director S-Sale D Common Stock 7,500 36.28 272.1K 95,834
2020-08-28 FORMICA FRANK J Director S-Sale D Common Stock 4,500 35.68 160.6K 60,000
2020-07-31 SCHWEITZER ROBERT C Director A-Award A Common Stock 7,500 31.20 234.0K 103,334
2020-07-31 ROSENBLOOM BRUCE S Officer A-Award A Common Stock 9,775 31.20 305.0K 41,525
2020-07-31 KORN RONALD J Director A-Award A Common Stock 7,500 31.20 234.0K 91,333
2020-07-31 FULGONI GIAN Director A-Award A Common Stock 7,500 31.20 234.0K 66,400
2020-07-31 FORMICA FRANK J Director A-Award A Common Stock 7,500 31.20 234.0K 64,500
2020-07-31 Campbell Leslie C.G. Director A-Award A Common Stock 7,500 31.20 234.0K 22,500
2020-07-31 AKDAG MENDERES Director / Officer A-Award A Common Stock 37,800 31.20 1.18M 397,800
2020-07-16 AKDAG MENDERES Director / Officer S-Sale D Common Stock 30,000 41.00 1.23M 360,000
2020-04-29 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 3,334 40.00 133.4K 31,550
2020-04-27 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 3,500 35.00 122.5K 34,884
2020-04-16 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 3,500 32.50 113.8K 38,384
2020-04-07 AKDAG MENDERES Director / Officer S-Sale D Common Stock 20,000 31.25 625.0K 390,000
2020-04-06 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 3,500 30.00 105.0K 41,884
2020-04-06 AKDAG MENDERES Director / Officer S-Sale D Common Stock 20,000 30.25 605.0K 410,000
2020-04-03 AKDAG MENDERES Director / Officer S-Sale D Common Stock 10,000 29.50 295.0K 430,000
2020-02-21 AKDAG MENDERES Director / Officer S-Sale D Common Stock 10,000 29.00 290.0K 440,000
2020-02-19 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 3,500 28.22 98.8K 45,384
2020-02-18 AKDAG MENDERES Director / Officer S-Sale D Common Stock 2,381 28.00 66.7K 450,000
2020-02-14 AKDAG MENDERES Director / Officer S-Sale D Common Stock 57,619 28.11 1.62M 452,381
2019-10-23 FULGONI GIAN Director S-Sale D Common Stock 12,000 26.45 317.4K 58,900
2019-10-23 FORMICA FRANK J Director D-Return D Common Stock 6,500 26.19 170.2K 57,000
2019-07-26 SCHWEITZER ROBERT C Director A-Award A Common Stock 7,500 15.98 119.9K 95,834
2019-07-26 ROSENBLOOM BRUCE S Officer A-Award A Common Stock 9,450 15.98 151.0K 48,884
2019-07-26 KORN RONALD J Director A-Award A Common Stock 7,500 15.98 119.9K 83,833
2019-07-26 FULGONI GIAN Director A-Award A Common Stock 7,500 15.98 119.9K 70,900
2019-07-26 FORMICA FRANK J Director A-Award A Common Stock 7,500 15.98 119.9K 63,500
2019-07-26 Campbell Leslie C.G. Director A-Award A Common Stock 7,500 15.98 119.9K 15,000
2019-07-26 AKDAG MENDERES Director / Officer A-Award A Common Stock 40,000 15.98 639.2K 510,000
2018-09-13 SCHWEITZER ROBERT C Director S-Sale D Common Stock 7,500 37.00 277.5K 88,334
2018-07-27 SCHWEITZER ROBERT C Director A-Award A Common Stock 7,500 35.43 265.7K 95,834
2018-07-27 ROSENBLOOM BRUCE S Officer A-Award A Common Stock 10,500 35.43 372.0K 39,434
2018-07-27 KORN RONALD J Director A-Award A Common Stock 7,500 35.43 265.7K 76,333
2018-07-27 FULGONI GIAN Director A-Award A Common Stock 7,500 35.43 265.7K 63,400
2018-07-27 FORMICA FRANK J Director A-Award A Common Stock 7,500 35.43 265.7K 56,000
2018-07-27 Campbell Leslie C.G. Director D PETMED EXPRESS, INC. COMMON STOCK 0 0.00 7,500
2018-06-12 FORMICA FRANK J Director S-Sale D Common Stock 5,000 41.78 208.9K 48,500
2018-01-29 KORN RONALD J Director S-Sale D Common Stock 5,000 48.38 241.9K 68,833
2018-01-22 AKDAG MENDERES Director / Officer S-Sale D Common Stock 10,000 57.00 570.0K 470,000
2018-01-12 AKDAG MENDERES Director / Officer S-Sale D Common Stock 10,000 53.00 530.0K 480,000
2018-01-11 AKDAG MENDERES Director / Officer S-Sale D Common Stock 30,000 51.00 1.53M 490,000
2017-12-15 FULGONI GIAN Director S-Sale D Common Stock 20,000 44.38 887.6K 55,900
2017-10-27 KORN RONALD J Director S-Sale D Common Stock 1,000 35.57 35.6K 73,833
2017-08-01 SCHWEITZER ROBERT C Director S-Sale D Common Stock 2,500 49.18 123.0K 88,334
2017-07-28 SCHWEITZER ROBERT C Director A-Award A Common Stock 7,500 48.37 362.8K 91,334
2017-07-28 ROSENBLOOM BRUCE S Officer A-Award A Common Stock 10,500 48.37 507.9K 28,934
2017-07-28 KORN RONALD J Director A-Award A Common Stock 7,500 48.37 362.8K 74,833
2017-07-28 FULGONI GIAN Director A-Award A Common Stock 7,500 48.37 362.8K 75,900
2017-07-28 FORMICA FRANK J Director A-Award A Common Stock 7,500 48.37 362.8K 53,500
2017-07-27 SCHWEITZER ROBERT C Director S-Sale D Common Stock 5,000 48.60 243.0K 83,834
2017-07-27 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 6,833 50.18 342.9K 18,534
2017-05-16 FORMICA FRANK J Director S-Sale D Common Stock 5,000 35.32 176.6K 46,000
2017-05-10 KORN RONALD J Director S-Sale D Common Stock 3,000 31.84 95.5K 72,333
2017-05-10 FULGONI GIAN Director S-Sale A Common Stock 35,000 32.22 1.13M 68,400
2017-05-08 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 9,000 27.00 243.0K 25,267
2017-05-01 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,500 24.00 36.0K 34,267
2016-12-13 AKDAG MENDERES Director / Officer S-Sale D Common Stock 10,000 23.00 230.0K 520,000
2016-12-09 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,500 23.00 34.5K 35,767
2016-12-07 AKDAG MENDERES Director / Officer S-Sale D Common Stock 2,674 22.75 60.8K 530,000
2016-12-06 AKDAG MENDERES Director / Officer S-Sale D Common Stock 433 22.75 9.9K 532,674
2016-12-01 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,500 22.50 33.8K 37,267
2016-12-01 AKDAG MENDERES Director / Officer S-Sale D Common Stock 16,893 22.60 381.8K 533,107
2016-11-25 AKDAG MENDERES Director / Officer S-Sale D Common Stock 6,274 22.25 139.6K 550,000
2016-11-21 AKDAG MENDERES Director / Officer S-Sale D Common Stock 3,726 22.25 82.9K 556,274
2016-11-16 FORMICA FRANK J Director S-Sale D Common Stock 10,000 21.75 217.5K 51,000
2016-11-14 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 3,000 21.75 65.3K 38,767
2016-11-14 AKDAG MENDERES Director / Officer S-Sale D Common Stock 30,000 21.75 652.5K 560,000
2016-11-11 AKDAG MENDERES Director / Officer S-Sale D Common Stock 10,000 21.25 212.5K 590,000
2016-10-10 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,500 21.00 31.5K 41,767
2016-10-10 AKDAG MENDERES Director / Officer S-Sale D Common Stock 10,000 21.00 210.0K 600,000
2016-09-22 AKDAG MENDERES Director / Officer S-Sale D Common Stock 10,000 20.75 207.5K 610,000
2016-08-12 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 8,000 20.38 163.0K 43,267
2016-08-11 SCHWEITZER ROBERT C Director S-Sale D Common Stock 1,500 20.57 30.9K 88,834
2016-08-10 SCHWEITZER ROBERT C Director S-Sale D Common Stock 1,500 20.60 30.9K 90,334
2016-08-09 SCHWEITZER ROBERT C Director S-Sale D Common Stock 3,000 20.51 61.5K 91,834
2016-08-08 SCHWEITZER ROBERT C Director S-Sale D Common Stock 1,500 20.55 30.8K 94,834
2016-08-01 KORN RONALD J Director S-Sale D Common Stock 4,000 20.76 83.0K 75,333
2016-07-29 SCHWEITZER ROBERT C Director A-Award A Common Stock 7,500 20.73 155.5K 96,334
2016-07-29 KORN RONALD J Director A-Award A Common Stock 7,500 20.73 155.5K 79,333
2016-07-29 FULGONI GIAN Director A-Award A Common Stock 7,500 20.73 155.5K 104,400
2016-07-29 FORMICA FRANK J Director A-Award A Common Stock 7,500 20.73 155.5K 61,000
2016-07-22 ROSENBLOOM BRUCE S Officer A-Award A Common Stock 10,500 19.60 205.8K 51,267
2016-05-09 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 4,000 19.93 79.7K 40,767
2016-05-06 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,500 18.50 27.8K 44,767
2016-03-30 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,500 18.00 27.0K 46,267
2016-03-16 AKDAG MENDERES Director / Officer A-Award A Common Stock 120,000 17.47 2.10M 620,000
2016-03-14 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,500 17.50 26.3K 47,767
2016-03-11 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,500 17.00 25.5K 49,267
2016-02-22 KORN RONALD J Director S-Sale D Common Stock 5,000 16.76 83.8K 71,833
2016-01-22 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 750 18.50 13.9K 50,767
2015-11-20 KORN RONALD J Director S-Sale D Common Stock 1,000 17.01 17.0K 76,833
2015-08-07 KORN RONALD J Director S-Sale D Common Stock 4,000 16.74 67.0K 77,833
2015-07-24 SCHWEITZER ROBERT C Director A-Award A Common Stock 7,500 17.02 127.7K 88,334
2015-07-24 ROSENBLOOM BRUCE S Officer A-Award A Common Stock 10,000 17.02 170.2K 51,517
2015-07-24 KORN RONALD J Director A-Award A Common Stock 7,500 17.02 127.7K 81,833
2015-07-24 FULGONI GIAN Director A-Award A Common Stock 7,500 17.02 127.7K 95,900
2015-07-24 FORMICA FRANK J Director A-Award A Common Stock 7,500 17.02 127.7K 53,500
2015-07-14 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 400 18.25 7.3K 41,517
2015-07-13 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 100 18.25 1.8K 41,917
2015-06-19 ROSENBLOOM BRUCE S Officer S-Sale D Common Stock 1,000 17.88 17.9K 42,017

Executive team

Top executives
Shares Outstanding
21.40M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Sandra Campos, Chief Executive Officer and President 497.0K 120.0K 3.26M 17.6K 3.89M 83.71%
2 2025 Robyn D’Elia, Chief Financial Officer 212.5K 920.0K 8.2K 1.14M 80.65%
3 2025 Christine Chambers, Former Chief Financial Officer 155.8K 10.0K 344.3K 11.3K 521.4K 66.04%
4 2025 Douglas Krulik, Chief Accounting Officer 173.1K 147.2K 16.4K 336.7K 43.72%
5 2025 Mathew N. Hulett, Former Chief Executive Officer and President 76.9K 166.1K 243.0K 0.00%
6 2024 Christine Chambers, Former Chief Financial Officer 375.0K 233.9K 26.3K 635.3K 36.82%
7 2024 Christine Chambers, Chief Financial Officer 375.0K 233.9K 26.3K 635.3K 36.82%
8 2024 Mathew N. Hulett, Former Chief Executive Officer and President 500.0K 34.0K 534.0K 0.00%
9 2023 Christine Chambers, Chief Financial Officer 238.0K 50.0K 346.1K 17.4K 651.5K 53.12%
10 2023 Christine Chambers, Former Chief Financial Officer 238.0K 50.0K 346.1K 17.4K 651.5K 53.12%
11 2023 Bruce S. Rosenbloom, Former Chief Financial Officer 274.5K 306.4K 580.9K 0.00%
12 2023 Mathew N. Hulett, Former Chief Executive Officer and President 500.0K 34.1K 534.1K 0.00%
13 2022 Mathew N. Hulett, Former Chief Executive Officer and President 278.8K 12.30M 20.8K 12.60M 97.62%
14 2022 Mathew N. Hulett, Chief Executive Officer and President 278.8K 12.30M 20.8K 12.60M 97.62%
15 2022 Menderes Akdag, Former Chief Executive Officer and President 229.0K 1.01M 1.24M 0.00%
16 2022 Bruce S. Rosenbloom, Chief Financial Officer 356.1K 1.2K 468.5K 130.7K 956.5K 48.98%
17 2022 Bruce S. Rosenbloom, Former Chief Financial Officer 356.1K 1.2K 468.5K 130.7K 956.5K 48.98%
18 2021 Menderes Akdag, Chief Executive Officer and President 619.9K 1.18M 395.3K 2.19M 53.74%
19 2021 Menderes Akdag, Former Chief Executive Officer and President 619.9K 1.18M 395.3K 2.19M 53.74%
20 2021 Bruce S. Rosenbloom, Chief Financial Officer 336.6K 1.2K 311.2K 135.7K 784.7K 39.66%
21 2021 Bruce S. Rosenbloom, Former Chief Financial Officer 336.6K 1.2K 311.2K 135.7K 784.7K 39.66%
22 2020 Menderes Akdag, Former Chief Executive Officer and President 617.8K 639.2K 46.5K 1.30M 49.04%
23 2020 Menderes Akdag, Chief Executive Officer and President 617.8K 639.2K 46.5K 1.30M 49.04%
24 2020 Bruce S. Rosenbloom, Chief Financial Officer 327.1K 1.0K 151.0K 94.0K 573.1K 26.35%
25 2019 Bruce S. Rosenbloom, Chief Financial Officer 320.4K 1.0K 372.0K 172.9K 866.3K 42.94%
26 2019 Menderes Akdag, Chief Executive Officer and President 600.0K 257.6K 857.6K 0.00%
27 2018 Menderes Akdag, Chief Executive Officer and President 600.0K 621.5K 1.22M 0.00%
28 2018 Bruce S. Rosenbloom, Chief Financial Officer 302.4K 900.00 507.9K 198.6K 1.01M 50.30%
29 2017 Menderes Akdag, Chief Executive Officer and President 600.0K 313.1K 913.1K 0.00%
30 2017 Bruce S. Rosenbloom, Chief Financial Officer 289.5K 600.00 205.8K 110.7K 606.6K 33.93%
31 2016 Menderes Akdag, Chief Executive Officer and President 550.0K 2.10M 248.5K 2.89M 72.42%
32 2016 Bruce S. Rosenbloom, Chief Financial Officer 280.0K 450.00 170.2K 95.7K 546.4K 31.15%
33 2015 Menderes Akdag, Chief Executive Officer and President 550.0K 222.1K 772.1K 0.00%
34 2015 Menderes Akdag, Chief Executive Officer and President 550.0K 222.1K 772.1K 0.00%
35 2015 Bruce S. Rosenbloom, Chief Financial Officer 273.6K 450.00 140.4K 79.7K 494.2K 28.41%
36 2015 Bruce S. Rosenbloom, Chief Financial Officer 273.6K 450.00 140.4K 79.7K 494.2K 28.41%
37 2014 Menderes Akdag, Chief Executive Officer and President 550.0K 186.7K 736.7K 0.00%
38 2014 Menderes Akdag, Chief Executive Officer and President 550.0K 186.7K 736.7K 0.00%
39 2014 Bruce S. Rosenbloom, Chief Financial Officer 267.9K 500.00 167.5K 84.7K 520.6K 32.17%
40 2014 Bruce S. Rosenbloom, Chief Financial Officer 267.9K 500.00 167.5K 84.7K 520.6K 32.17%
41 2013 Menderes Akdag, Chief Executive Officer and President 550.0K 1.55M 232.3K 2.33M 66.39%
42 2013 Bruce S. Rosenbloom, Chief Financial Officer 262.1K 500.00 97.0K 61.8K 421.3K 23.02%
43 2012 Menderes Akdag, Chief Executive Officer and President 550.0K 190.2K 740.2K 0.00%
44 2012 Bruce S. Rosenbloom, Chief Financial Officer 255.1K 500.00 109.7K 67.0K 432.2K 25.38%
45 2011 Menderes Akdag, Chief Executive Officer and President 550.0K 226.4K 776.4K 0.00%
46 2011 Bruce S. Rosenbloom, Chief Financial Officer 245.3K 159.5K 77.7K 482.5K 33.06%
47 2010 Menderes Akdag, Chief Executive Officer and President 450.0K 2.80M 224.2K 3.47M 80.57%
48 2010 Bruce S. Rosenbloom, Chief Financial Officer 232.2K 1.8K 167.0K 72.2K 473.2K 35.30%
49 2009 Menderes Akdag, Chief Executive Officer and President 450.0K 163.6K 613.6K 0.00%
50 2009 Bruce S. Rosenbloom, Chief Financial Officer 211.1K 1.6K 118.0K 47.0K 377.7K 31.23%
51 2008 Menderes Akdag, Chief Executive Officer and President 450.0K 143.4K 593.4K 0.00%
52 2008 Bruce S. Rosenbloom, Chief Financial Officer 190.2K 1.2K 97.6K 33.0K 321.9K 30.31%
53 2007 Menderes Akdag, Chief Executive Officer and President 254.6K 30.4K 360.8K 24.2K 670.0K 58.39%
54 2007 Bruce S. Rosenbloom, Chief Financial Officer 146.1K 1.0K 16.2K 49.5K 22.5K 235.2K 27.91%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2025-12-10 DEF 14A
2024-07-02 DEFA14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-06-02 8-K
2026-06-02 10-K
2026-05-21 8-K
2026-02-11 SC 13D
2026-02-05 10-Q
2026-01-23 8-K
2026-01-23 4
2025-12-29 8-K/A
2025-12-19 10-Q
2025-12-19 10-Q

Executive team

NameTitleCompensationGender
Doug Krulik Chief Accounting Officer, Principal Acc. Off., Interim Principal Financial Officer & Treasurer 276.0K male
Leslie C. G. Campbell Executive Chairman of the Board, Interim CEO & President 53.8K female
Jacqueline Smith Vice President of People female
Caroline Conegliano Chief Operating Officer female
Robert Lawsky Corporate Secretary & General Counsel male
Umesh Sripad Chief Digital & Technology Officer male
Wendy Zalai Corporate Controller & Corporate Secretary
ESG Rating
B
MEDICAL - PHARMACEUTICALS
2023
E (Environmental)
68.5 / 59.0
Company / Sector avg.
S (Social)
70.7 / 64.8
Company / Sector avg.
G (Governance)
66.3 / 59.6
Company / Sector avg.
ESG Total
68.5 / 61.2
Company / Sector avg.
ESG Score History MEDICAL - PHARMACEUTICALS
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits